Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
Biostock interview with CEO Peter Egelberg
New CEO commentary — “Redefining aging with HoloMonitor”
In the CEO commentary “Redefining aging with HoloMonitor” Peter Egelberg comments on the promising research results that were recently reported by Australian television.
PHI at the Nordic Microscopy Society meeting, June 25-28
The Nordic Microscopy Society meeting in Lyngby Denmark offers several opportunities to meet with us and to hear about the latest HoloMonitor news.
We believe we’ve found the Holy Grail
We believe we’ve found the Holy Grail” Associate Professor Derek Richard, at Queensland University of Technology in Australia, has, with help from HoloMonitor M4, found a way to turn back time and make old cells young again.
Notice of Extraordinary General Meeting in Phase Holographic Imaging PHI AB (publ)
Notice to the shareholders in Phase Holographic Imaging AB (publ), 556542-7811, to attend an Extraordinary General Meeting on Monday June 18 at 06.00 PM (18.00) at PHI’s office, Scheelevägen 22, Lund.
Decision on rights issue for continued growth, establishment of sales organization and commercial break-through
The Board of directors of Phase Holographic Imaging PHI AB (publ) (”PHI”) has decided to conduct a rights issue of units, which is subject to approval on Extraordinary General Meeting, that can provide the company a total of SEK 64.6 million at the most prior to issuing costs.
HoloMonitor M4 at Pazmany Peter Catholic University
Dr Garay Tamás’ research focuses on cell migration and proliferation in cancer cells. HoloMonitor M4, with it’s potential to track cell events in a cell friendly environment inside the incubator will, hopefully, be a helpful tool for Dr Garay Tamas in his future research.
PHI increase sales in fourth quarter, as well
PHI hereby announces that net sales during the fourth and final fiscal quarter of 2017/18 amounted to 2.2 (1.2) MSEK, resulting in that the company saleswise achieves its best quarter ever for the second consecutive quarter.
PHI and world-leading research institute evaluate quantitative imaging of living tumor cells
QIMR Berghofer Medical Research Institute in Brisbane and PHI have entered an evaluation agreement to explore the use of live cell time-lapse cytometry based on quantitative phase microscopy to determine the impact of hypoxic microenvironment on cellular motility and metastatic potential in solid cancers.
AACR 2018
Phase Holographic Imaging | AACR 2018 Be among the first to see a walk-through of the HoloMonitor App Suite – a new proprietary software for analysis of images and data, especially developed for cell biological applications. Meet us for a demo – visit our booth #1740.